1. Home
  2. Calendar of Events
  3. Pathology in the Park

Pathology in the Park

LEARN WITH A VIEW

In a time of competing priorities, our Pathology in the Park program is an educational experience combining focused CME curriculum with built-in leisure time so you can maintain a positive work-life balance. Internationally-known faculty will provide insights on topics you encounter every day in pathology practice that will enhance your ability to improve patient care and practice efficiency.

Pathology in the Park – June 22-25, 2020

Sitting just outside the idyllic backdrop of Yosemite National Park, Tenaya Lodge is the perfect setting for a program emphasizing balance. The 2020 program will focus on breast pathology, gastrointestinal pathology, and hematopathology. Education sessions take place during morning hours, leaving afternoons free for participants to explore the park with fellow attendees or their families to take advantage of the many activities the park provides. Features of this program include:

  • 1:00 PM start on day one allowing you to arrive and kick-off your experience relaxed and stress-free.
  • Morning-to-noon education sessions Tuesday – Thursday so you can have time to enjoy the many offerings the park provides.
  • 45–50 minute presentations, with time built-in for participant interaction and questions/answers.
  • Ample opportunity to network with faculty and fellow program participants in a relaxed environment.
  • 20 CME/SAM credits with SAMs offered via online post-tests.

Learning Objectives

As an outcome of this program, you will learn to:

  1. Identify, assess, and diagnose neoplastic and non-neoplastic entities and their mimickers in gastrointestinal, breast, and hematopathology.
  2. Recognize and avoid diagnostic pitfalls that expert faculty and peers have encountered in everyday practice.
  3. Manage common diagnostic challenges.
  4. Apply recent evidence-based guidelines and developments in ancillary testing to your day-to-day work.
  5. Demonstrate your knowledge and comprehension via activities and audience participation.

2020 Program Schedule

  • Open all Toggle
  • Close all Toggle
1:00-1:15 PMWelcome
1:15-2:15 PMBeyond Reflux Esophagitis: All About the Esophagus
Mary Kay Washington, MD, PhD
2:15-3:15 PMNeoplasia of the Gastroesophageal Junction and Stomach, including Biomarker Testing
Mary Kay Washington, MD, PhD
3:15-3:45 PMBreak
3:45-4:45 PMApproach to the Diagnosis of Non-neoplastic Lymph Node Specimens
Devon Chabot-Richards, MD, FCAP
4:45-5:45 PMLymphoproliferative Disorders Manifesting in Blood
Kathryn Foucar, MD, FCAP
5:45-7:45 PMSocial Event – Families Invited
7:00-7:30 AMContinental Breakfast (attendees only)
7:30-8:30 AMCommon Core Breast Biopsy Diagnostic Challenges
Laura C. Collins, MD, FCAP
8:30-9:30 AMIntraductal Proliferative Breast Disease
Timothy M. D’Alfonso, MD
9:30-10:00 AMBreak
10:00-11:00 AMColorectal Cancer: Prognostic Factors, Staging, and Biomarker Testing for the Surgical Pathologist
Mary Kay Washington, MD, FCAP
Raul S. Gonzalez, MD, FCAP
11:00 AM- 12:00 PMIntestinal Neoplasia, From Mundane to Malignant
Raul S. Gonzalez, MD, FCAP
7:00-7:30 AMContinental Breakfast (attendees only)
7:30-8:30 AMMyelodysplasia and Mimics
Kathryn Foucar, MD, FCAP
8:30-9:30 AMNext-Generation Sequencing in Clonal Myeloid Disorders: CHIP, CCUS, and Beyond
Devon Chabot-Richards, MD, FCAP
9:30-10:00 AMBreak
10:00-11:00 AMPrognostic and Predictive Testing in Breast Cancer: An Update
Laura C. Collins, MD, FCAP
11:00 AM-12:00 PMPitfalls in the Use of IHC in Diagnostic Breast Pathology
Timothy M. D’Alfonso, MD
7:00-7:30 AMContinental Breakfast (attendees only)
7:30-8:30 AMConquering Colitis: Patterns of Injury and Differential Diagnoses
Raul S. Gonzalez, MD, FCAP
8:30-9:30 AMAggressive B-Cell Lymphomas
Devon Chabot-Richards, MD, FCAP
9:30-10:00 AMBreak
10:00-11:00 AMPapillary Proliferations of the Breast
Laura C. Collins, MD, FCAP
11:00 AM-12:00 PMUnusual Breast Lesions
Timothy M. D’Alfonso, MD

Meet the Faculty

  • Open all Toggle
  • Close all Toggle

Devon Chabot-Richards, MD, FCAP, completed her pathology residency and hematopathology and molecular genetic pathology fellowships at the University of New Mexico. She is currently an associate professor of pathology at the University of New Mexico, where she serves as director of the Molecular Diagnostics and Oncology Laboratory and signs out on the hematopathology and molecular services. She is the coauthor of Diagnostic Pathology: Blood and Bone Marrow and Diagnostic Pathology and has authored chapters in several other textbooks. She has been an invited speaker at national meetings for the CAP and other professional organizations. Her areas of interest in hematopathology include myeloid disorders, benign and malignant lymph node pathology, and the incorporation of molecular testing into diagnosis, prognosis, and treatment algorithms. Her experience has taught her that morphologic findings are key in guiding the appropriate and informed utilization of ancillary tests, including IHC, flow cytometry, cytogenetics, and FISH, and molecular tests including next-generation sequencing panels.

Laura C. Collins, MD, FCAP, is the vice chair of anatomic pathology and director of breast pathology at Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts. She is a professor of pathology at Harvard Medical School. Dr. Collins graduated from Charing Cross and Westminster Medical School in London and completed her anatomic and clinical pathology residency training at the Beth Israel Hospital in Boston followed by a cytopathology fellowship at the same institution. In 1998, Dr. Collins joined the faculty at BIDMC as a staff pathologist. During her tenure at BIDMC she has served as the director of the Residency Training Program in anatomic and clinical pathology as well as the director of the Selective Pathology Fellowship Training Program. Nationally, she has served the United States and Canadian Academy of Pathology as a member of the Education Committee, chair of the Residency Advisory Subcommittee, and she is currently a member of the United States and Canadian Academy of Pathology (USCAP) Board of Directors. She has also served as the president of the Arthur Purdy Stout Society of Surgical Pathologists.

Dr. Collins is an internationally renowned breast pathologist. She has published numerous original articles, review articles, and book chapters on breast pathology. She has twice been the guest editor for a monograph on Current Concepts in Breast Pathology: Surgical Pathology Clinics Series. Along with Dr. Stuart Schnitt, she has published a pathology textbook entitled Biopsy Interpretation of the Breast, now in its third edition and she was a contributor to several chapters in the WHO Classification of Tumours of the Breast (Medicine) (2012 and 2019). 

Her research interests are in breast cancer, and in particular the understanding of precursor lesions and early breast neoplasia. In addition to her work in research, Dr. Collins is a committed educator, giving numerous lectures and postgraduate CME courses around the US and the world to support the ongoing education of pathologists and pathologists-in-training in the diagnosis of breast disease.

Timothy M. D’Alfonso, MD, is an associate attending pathologist at Memorial Sloan Kettering Cancer Center with clinical and research interests focused on diseases of the breast, including breast cancer. Dr. D’Alfonso earned his medical degree from Rosalind Franklin University of Medicine and Science/Chicago Medical School. He completed residency training in anatomic pathology followed by a fellowship in breast pathology at New York-Presbyterian Hospital/Weill Cornell Medicine. He was a member of the faculty at Weill Cornell Medicine as an instructor and assistant professor of pathology and laboratory medicine, where he served as director of the Breast Pathology Fellowship Program. Dr. D’Alfonso has published several peer-reviewed journal articles and textbook chapters on the subject of breast pathology. He is an ad hoc reviewer for numerous journals and has served as an abstract reviewer for the United States and Canadian Academy of Pathology (USCAP). He has lectured in courses at national pathology conferences, including USCAP, the American Society for Clinical Pathology (ASCP), and the CAP annual meetings.

Kathryn Foucar, MD, FCAP, completed her pathology training and surgical pathology fellowship at University of New Mexico (UNM)/University of Minnesota. She is currently a distinguished professor emerita at the University of New Mexico. She has over 38 years of practice experience focused on diagnostic hematopathology. She and Dr. Cheryl Willman established the Hematopathology Fellowship at UNM in 1989. To date 83 fellows have been trained at UNM. Dr. Foucar has published 123 peer reviewed papers, over 100 book chapters, and she is the author/coauthor of several hematopathology books including Bone Marrow Pathology (4th edition in press), Diagnostic Pathology: Blood and Bone Marrow (2nd edition 2018), and Knowles Neoplastic Hematopathology (editor, 3rd edition 2014). She is coauthor of seven World Health Organization (WHO) 2016 chapters and coauthor on the American Society of Hematology (ASH)-CAP Clinical Practice Guidelines for the workup of acute leukemia. Her particular areas of interest in hematopathology include B- and T-cell neoplasms that involve blood and bone marrow, myelodysplasia and myelodysplastic syndrome mimics, and acute myeloid leukemia. Her general approach to these types of challenging cases includes practical strategies for case assessment and specialized testing based on correlation of clinical findings, CBC data, and morphologic features on blood smears as a starting point. Specialized testing including flow cytometric immunophenotyping, cytogenetics/FISH, and molecular genetic assessment is now the standard of care, but logical individual case-based testing strategies are essential. The pathologist must provide information that supports a diagnosis as well as providing prognostic information and facilitates targeted therapy decision-making and minimal residual disease monitoring.

Raul S. Gonzalez, MD, FCAP, is a staff pathologist at Beth Israel Deaconess Medical Center and an assistant professor at Harvard Medical School. He has been in practice for more than five years, focusing on gastrointestinal pathology. He actively posts educational content on his Twitter account and is the membership chair for the Rodger C. Haggitt Gastrointestinal Pathology Society. He also serves on the CAP Surgical Pathology Committee. His research led to refined criteria in staging of small bowel neuroendocrine tumors and improved recognition of the histopathologic spectrum of medication-induced colitis.

Mary Kay Washington, MD, FCAP, is a professor of pathology at Vanderbilt University Medical Center and an internationally known gastrointestinal and liver pathologist. She received her PhD and MD degrees from the University of North Carolina at Chapel Hill and trained at Duke in anatomic and clinical pathology before joining the faculty at Vanderbilt over 20 years ago. She is an author on over 350 scientific papers and 30 book chapters. Currently, Dr. Washington serves as vice chair of the CAP Center Guidelines Committee and is a member of the Council on Scientific Affairs, the Cancer Committee, and the Publications Committee. She has been a lead author on the CAP GastrointestinaI Cancer Protocols and a cochair for the CAP/ASCP/ASCO Guideline on HER2 Testing in Gastroesophageal Cancer. Dr. Washington is a member of the Executive Committee for the American Joint Committee on Cancer (AJCC) and an associate editor for the AJCC TNM Staging Manual, 8th edition. In 2018, she was appointed to the Standing Editorial Board for the fifth series of the World Health Organization Classification of Tumours books. Dr. Washington will share her insights as a practicing surgical pathologist as well as a leader in cancer staging and reporting to provide guidance on assessing prognostic factors in colorectal cancer and a practical approach to gastroesophageal neoplasia.

Registration

The cost of registration includes program tuition, networking event on Monday evening, and continental breakfast served Tuesday, Wednesday, and Thursday.

Once you register for the program, you will receive a confirmation and a link to make your hotel reservations.

  • Early Bird Through May 4, 2020

    • $799.00 Member
    • $1,040.00 Nonmember
  • Registration After May 4, 2020

    • $900.00 Member
    • $1,175.00 Nonmember

Hotel Information

Our inaugural Pathology in the Park program is at the Tenaya Lodge at Yosemite—an elegant resort in the California High Sierra. Tenaya Lodge is the gateway to Yosemite National Park adventures where you can rest, play, and rejuvenate.

Guests can enjoy hiking, mountain biking, scenic tours, guided tours, rock climbing, fishing, water sports, golf, horseback riding, whitewater rafting, fitness center, and spa. 

Note: Activities may incur an additional cost to participate. Tenaya Lodge’s Concierge Services can assist you to make arrangements. 

Room Rate

$279.00 Single/Double Occupancy + 11% tax + $30 daily resort fee for a total of $340.44 room cost per night. 

  • Children under 18: There is no additional charge for children under 18 years of age staying with an adult. 
  • Additional adult (over two): There will be a charge of $15.00 per night plus taxes.

Check-In Time: 4:00 PM PT

Check-Out Time: 11:00 AM PT

Tenaya Lodge
1122 CA-41
Fish Camp, CA 93623
(888) 514-2167

  • Reservations: Once registered, attendees will receive an email confirmation with directions to make room reservations with Tenaya Lodge online or via phone.
  • Room upgrade: If you wish to upgrade your accommodations or extend your stay, you will need to work with Tenaya Lodge reservations—any additional cost is the attendee’s responsibility and subject to hotel availability. Note, we only have rooms available the evenings of June 21 to 25, 2020. 
  • Cancellations: Individual guest rooms must be canceled 14 days or more before arrival to receive a full refund.

Transportation

Parking is free for Tenaya Lodge guests. For overnight parking, all food should be removed from your vehicle and placed in your room or a secure storage locker. 

Yosemite National Park Entrance Fees

All visitors at Yosemite National Park are required to pay an entrance fee. There are a variety of pass options to fit your needs. 

Purchase your pass  Arrow Right

Cancellation Policy

Should you need to cancel your registration for this program, please contact the CAP as soon as possible. The CAP will apply your payment to a future program or refund your registration fee, less a $100.00 processing fee, up to two weeks prior to the program; refunds after that date will be considered on a case-by-case basis.  

The CAP reserves the right to cancel any CME workshop without prior notice for insufficient preregistration or any other reason. The CAP is not responsible for participant airline or hotel cancellation penalties or any other losses incurred as a result of cancellation.

CME Information

Accreditation: The College of American Pathologists (CAP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Category 1: The College of American Pathologists designates this live educational activity for a maximum of 20.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity meets the American Board of Pathology’s (ABP) Continuing Certification (CC) requirements for Self-Assessment Modules (SAMs).

Save With Early Bird Pricing

Register for Pathology in the Park before May 4, 2020 to receive a reduced registration rate.